TY - JOUR
T1 - Updates to the <em>Standards of Medical Care in Diabetes—2018</em>
JF - Diabetes Care
JO - Diabetes Care
SP - 2045
LP - 2047
M3 - 10.2337/dc18-su09
VL - 41
IS - 9
AU - ,
Y1 - 2018/09/01
UR - http://care.diabetesjournals.org/content/41/9/2045.abstract
N2 - The American Diabetes Association’s (ADA’s) Standards of Medical Care in Diabetes (Standards of Care) provide the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2, or gestational diabetes mellitus; strategies to improve the prevention or delay of type 2 diabetes; and therapeutic approaches that reduce complications and positively affect health outcomes. New in 2018, the ADA is updating and revising the online version of the Standards of Care throughout the year with annotations for new evidence or regulatory changes that merit immediate incorporation (1). The annotated Standards of Care issue is available online at care.diabetesjournals.org/content/41/Supplement_1. Updates to the 2018 Standards of Care appear below and can be accessed by clicking on the yellow highlighted text in the online issue. More information about the “living” Standards of Care, including the methodology used for reviewing and approving updates, is available at care.diabetesjournals.org/living-standards.(Sections 6 and 14): The December 2017 issue of Diabetes Care featured a consensus report (2) from the ADA and others in the diabetes community on clinically meaningful outcome measures beyond A1C for type 1 diabetes, which categorized hypoglycemia into three levels. The ADA has updated Section 6 Glycemic Targets and Section 14 Diabetes Care in the Hospital of the 2018 Standards of Care to align with the hypoglycemia definitions in the consensus report (2) and thereby minimize confusion for practitioners. The following updates were approved on 10 March 2018 and added to the living Standards of Care on 11 April 2018.Table 6.3 (p. S61)Table 6.3 has been updated to align with the recently published Consensus Report titled: “Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of …
ER -